Cannabis Policy
Medical Cannabis Legalization Not Linked With Fewer Opioid Prescriptions, Study Finds
US states that legalize medical cannabis don’t tend to see a decline in opioid prescriptions for non-cancer pain. That’s the main finding of a new study from researchers at Weill Cornell Medicine.
FDA and FTC Sends Warning Letters to Delta-8 THC Brands Over Their Child-Friendly Packaging
The FTC say this kind of marketing is “reckless” as the emulated products are appealing to children.
FDA Releases Draft Guidance For Psychedelic Drugs Research
Comments from the public and relevant professionals are welcome and will be accepted until August 25.
Oregon Regulator Recalls Cannabis Flower Due to Aspergillus and Heavy Metal Contamination
The batches were harvested between October 2022 and January 2023 by three separate cultivators.
Nevada Consumers Advised to Avoid Cannabis Flower That Tested Positive For Aspergillus
Cannabis consumers in Nevada have been advised by the state’s cannabis regulator to avoid or “take caution” when consuming the “Dancing Monkey” product.
Oklahoma Has 32 Times More Medical Cannabis Than It Needs, Study Finds
Given this vast oversupply of cannabis, the study says it is likely that, to offload their products, many licensed medical cannabis businesses are supplying the state’s illicit market.
Opinion: Why Medical Cannabis Patients Should Stay Away From the Illicit Market
Brady Green, head grower at UK-based medicinal cannabis firm Dalgety, explains the differences between the country's illicit and legal medical cannabis markets, and why the latter needs to be the first-choice for patients.
Arizona Dispensaries Recall Cannabis Concentrates Due to Salmonella Risk
As of June 14, no illnesses have been linked to the products.
‘Many’ Cannabis Samples Are Adulterated in Colorado, Says Regulator
The cannabis regulator in Colorado has identified ‘many examples’ of adulterated test batches, according to a recent notice.
